Delivery Order SPE2DB22D3016-SPE2DB24FBGT4
Award Date 9/12/24
Potential Completion Date 9/13/24
Potential Value $4.6K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a $4,647.12 firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of MONOVISC 88 MG/4 ML SYRINGE 4ML pharmaceutical products. The contract has an ultimate completion date of July 25, 2024. AmerisourceBergen, a major pharmaceutical distributor, is providing these medical supplies to support military treatment facilities and other federal healthcare providers. The award is not associated with a set-aside program....
- This is a $4,647.12 firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The order is for the supply of MONOVISC 88 MG/4 ML SYRINGE 4ML, a pharmaceutical product. The delivery order falls under a larger $999,999,999.00 indefinite delivery contract (IDC) between DLA and Amerisourcebergen Drug Corp, which serves as the primary vehicle for Amerisourcebergen to provide pharmaceuticals and...
- This is a $4,906.14 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corporation's Corporate Office division. The contract is to supply 4,565,477,808 units of the MONOVISC 88 MG/4 ML SYRINGE 4ML medical device by August 19, 2024. This delivery order is part of Amerisourcebergen's larger Indefinite Delivery Contract with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, to...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide MONOVISC 88 MG/4 ML SYRINGE 4ML medical supplies. The $4,647.12 contract has a completion date of February 21, 2024 and does not have a set-aside designation. AmerisourceBergen Drug Corp serves as a prime contractor providing a range of pharmaceutical products and medical supplies to U.S. government agencies,...
- This is a $1,936.25 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division. The contract is for the supply of 4,565,242,943 units of the pharmaceutical product MONOVISC 88 MG/4 ML SYRINGE 4ML, with an ultimate completion date of July 25, 2024. AmerisourceBergen, a major pharmaceutical distributor, has been awarded this delivery order as part of its broader role as an Indefinite Delivery Contract (IDC) holder with...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $46,913.53 firm fixed-price contract is for the delivery of MONOVISC 88 MG/4 ML SYRINGE 4ML, a medical product, with a performance period running through June 7, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support...
- This is a $10,617.78 firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division. The contract is for the supply of MONOVISC 88 MG/4 ML SYRINGE 4ML, a pharmaceutical product, with a period of performance through August 6, 2024. Amerisourcebergen is a major supplier of pharmaceutical and medical products to the federal government, including military treatment facilities and other healthcare providers. This award is...
- This is a $13,643.69 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of parent company Cencora, Inc. The contract is for the delivery of MONOVISC 88 MG/4 ML SYRINGE 4ML, a pharmaceutical product, with a period of performance through April 16, 2024. Amerisourcebergen is a major supplier of pharmaceuticals and medical supplies to the U.S. federal government, primarily serving the Department of Defense (DoD) and...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp for the supply of MONOVISC 88 MG/4 ML SYRINGE 4ML, a pharmaceutical product. The $8,452.60 firm fixed price contract has an ultimate completion date of August 14, 2024. AmerisourceBergen, a major pharmaceutical distributor, was awarded this delivery order under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distributor Amerisourcebergen Corporation. The $4,647.12 contract is for the supply of MONOVISC 88 MG/4 ML SYRINGE 4ML, a specialty medical product. This delivery order is part of a larger indefinite delivery contract (IDC) awarded by DLA to Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 and a performance...